​

Regeneron Pharmaceuticals Ownership | Who Owns Regeneron Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Regeneron Pharmaceuticals Ownership Summary


Regeneron Pharmaceuticals is owned by 88.44% institutional investors, 2.08% insiders, and 9.48% retail investors. Vanguard group is the largest institutional shareholder, holding 8.82% of REGN shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 3.18% of its assets in Regeneron Pharmaceuticals shares.

REGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRegeneron Pharmaceuticals88.44%2.08%9.48%
SectorHealthcare Stocks 246.48%12.12%-158.60%
IndustryBiotech Stocks 384.82%11.76%-296.58%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group9.08M8.82%$7.00B
Blackrock funding, inc. /de9.11M8.76%$5.68B
Blackrock8.45M7.84%$8.88B
Vanguard capital management6.63M6.37%$4.13B
Dodge & cox4.87M4.68%$3.04B
State street4.83M4.65%$3.01B
Invesco3.94M3.79%$2.46B
Jpmorgan chase3.77M3.63%$2.38B
Franklin resources2.77M2.67%$1.73B
Geode capital management2.63M2.52%$1.63B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bronte capital management pty162.62K10.89%$101.40M
Mcdonald capital investors inc/ca172.65K10.75%$130.91M
Davern capital partners, lp92.64K9.85%$57.76M
Rk asset management12.66K9.22%$9.77M
Solas capital management18.22K6.25%$10.24M
Orion investment29.50K5.37%$18.40M
Southeastern asset management inc/tn/152.32K4.95%$94.98M
Guoline advisory pte67.30K4.39%$51.03M
Diadema partners lp30.16K4.34%$16.96M
Superstring capital management lp6.40K3.55%$3.60M

Top Buyers

HolderShares% AssetsChange
Invesco3.94M0.19%1.76M
Norges bank1.17M0.07%1.17M
Sixth street partners management company846.31K0.07%846.31K
Dodge & cox4.87M1.59%412.90K
Sg americas securities427.70K0.15%269.43K

Top Sellers

HolderShares% AssetsChange
Capital investors---876.56K
Fmr831.96K0.02%-686.23K
Price t rowe associates inc /md/1.53M0.10%-647.82K
Capital world investors814.92K0.06%-604.08K
Wellington management group llp1.27M0.14%-567.37K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.17M0.07%1.17M$731.29M
Sixth street partners management company846.31K0.07%846.31K$527.71M
Axa investment managers62.29K0.09%62.29K$35.02M
Smith group asset management40.11K1.99%40.11K$30.42M
Hrt financial lp36.09K0.04%36.09K$22.50M

Sold Out

HolderChange
Proffitt & goodson-1.00
Greenline partners-1.00
Triad wealth partners-1.00
Financial gravity asset management-1.00
Palisade asset management-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261,374-5.63%91,982,7453.63%881.21%603-15.55%53314.87%
Mar 31, 20261,416-2.07%85,326,286-4.30%811.09%698-9.11%449-2.18%
Dec 31, 2025930-28.68%49,033,116-43.67%470.69%498-24.89%295-27.34%
Sep 30, 2025813-35.17%39,624,504-53.33%370.58%418-25.36%267-43.79%
Jun 30, 20251,254-5.93%89,298,391-2.58%841.15%562-14.07%4692.85%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor3.27M3.18%-35.66K
Vanguard US Total Market Shares ETF3.44M3.14%178.74K
Vanguard Total Stock Mkt Idx Inv3.27M3.12%-35.66K
Vanguard MStar Total Stk Mkt Idx Invest3.21M3.12%-62.72K
Dodge & Cox Stock I3.09M3.00%-33.08K
Vanguard Institutional 500 Index Trust2.99M2.77%22.25K
Vanguard 500 Index Investor2.57M2.50%-79.31K
Invesco QQQ Trust2.11M2.05%-3.45K
iShares Core S&P 500 ETF1.31M1.27%-2.11K
Fidelity 500 Index1.30M1.26%4.98K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 14, 2026MURPHY ANDREW J Co-Chief Scientific OfficerSell$12.12K
Oct 14, 2026MURPHY ANDREW J Co-Chief Scientific OfficerSell$18.20K
Oct 14, 2026MURPHY ANDREW J Co-Chief Scientific OfficerSell$26.46K
Oct 14, 2026MURPHY ANDREW J Co-Chief Scientific OfficerSell$4.52K
Oct 14, 2026MURPHY ANDREW J Co-Chief Scientific OfficerSell$10.64K

Insider Transactions Trends


DateBuySell
2026 Q4-27
2026 Q3-6
2026 Q2-21
2026 Q1-49
2025 Q4-8

REGN Ownership FAQ


Who Owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals shareholders are primarily institutional investors at 88.44%, followed by 2.08% insiders and 9.48% retail investors. The average institutional ownership in Regeneron Pharmaceuticals's industry, Biotech Stocks , is 384.82%, which Regeneron Pharmaceuticals falls below.

Who owns the most shares of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals’s largest shareholders are Vanguard group (9.08M shares, 8.82%), Blackrock funding, inc. /de (9.11M shares, 8.76%), and Blackrock (8.45M shares, 7.84%). Together, they hold 25.42% of Regeneron Pharmaceuticals’s total shares outstanding.

Does Blackrock own Regeneron Pharmaceuticals?

Yes, BlackRock owns 7.84% of Regeneron Pharmaceuticals, totaling 8.45M shares as of Jun 2024. This represents 0.20% of BlackRock's total assets, with a market value of 8.88B$. In the last quarter, BlackRock decreased its holdings by -122K shares, a -1.43% change.

Who is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bronte capital management pty is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.89% of its assets in 162.62K Regeneron Pharmaceuticals shares, valued at 101.4M$.

Who is the top mutual fund holder of Regeneron Pharmaceuticals shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Regeneron Pharmaceuticals shares, with 3.18% of its total shares outstanding invested in 3.27M Regeneron Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools